Mark F. Bailey Sr. bought $788k of ZCAR
director at Zoomcar Holdings, Inc.. 184,112 shares at an average of $4.28, traded Nov 5, 2024, filed Dec 4, 2024.
Score components
- +15RoleDirector
- +22Trade size$788k at market
- +3Relative to holdingsHoldings up 14%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -62.0%, 3m -93.5%, 6m -98.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-24-105626, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 5, 2024 | POpen-market purchase Common Stock | +184,112 | $4.28 | $788k | 1,534,496 | Dec 4, 2024 |
| Nov 5, 2024 | POpen-market purchase Pre-Funded Warrants to purchase Common Stockderivative | +400,000 | $4.28 | $1.7M | 400,000 | Dec 4, 2024 |
| Nov 5, 2024 | POpen-market purchase Series A Warrants to purchase Common Stockderivative | +1,168,224 | - | - | 1,168,224 | Dec 4, 2024 |
| Nov 5, 2024 | POpen-market purchase Series B Warrants to purchase Common Stockderivative | +0 | - | - | 0 | Dec 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.